Literature DB >> 8849595

Cocaine-stimulated endothelin-1 release is decreased by angiotensin-converting enzyme inhibitors in cultured endothelial cells.

K D Hendricks-Munoz1, R P Gerrets, R D Higgins, J L Munoz, V V Caines.   

Abstract

OBJECTIVE: The primary aim was to determine the action of pathophysiologically relevant cocaine concentrations (10(-7)-10(-5) M) on endothelin-1 (ET-1) release from cultured endothelial cells under various cellular conditions. Further aims were to evaluate the effect of angiotensin-converting enzyme inhibitors on cocaine-treated endothelial cells, to assess their potential for inhibition of ET-1-stimulated release.
METHODS: Endothelin-1 release into the media was evaluated by radioimmunoassay under basal conditions and after 24 h treatment of endothelial cells with cocaine hydrochloride (HCl), or cocaine HCl and ACE inhibitors, captopril and lisinopril. The effect of serum and plasma under these conditions was also investigated.
RESULTS: Cocaine HCl stimulated ET-1 release in a dose response fashion that was independent of plasma or serum factors. Furthermore, cocaine-stimulated ET-1 release was inhibited by administration of angiotensin-converting enzyme inhibitors captopril and lisinopril.
CONCLUSIONS: These findings suggest that cocaine can directly stimulate endothelial cells to release ET-1 and that the observed increase is independent of serum or plasma factors. Furthermore, cocaine-stimulated endothelin-1 release appears to be mediated at least in part by the angiotensin system. These observations provide a framework for understanding the cellular mechanisms involved in cocaine-induced vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849595     DOI: 10.1016/s0008-6363(95)00168-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study.

Authors:  Hong Lai; Maxine Stitzer; Glenn Treisman; Richard Moore; Jeffrey Brinker; Gary Gerstenblith; Thomas S Kickler; Ji Li; Shaoguang Chen; Elliot Fishman; Shenghan Lai
Journal:  J Addict Med       Date:  2015 Jul-Aug       Impact factor: 3.702

2.  Lifetime Cocaine and Opiate Use and Chronic Kidney Disease.

Authors:  Tessa Novick; Yang Liu; Anika Alvanzo; Alan B Zonderman; Michele K Evans; Deidra C Crews
Journal:  Am J Nephrol       Date:  2016-10-28       Impact factor: 3.754

3.  Cocaine-induced acute interstitial nephritis: A case report and review of the literature.

Authors:  Rodrigo Alfaro; Nina Vasavada; Paisit Paueksakon; German T Hernandez; George R Aronoff
Journal:  J Nephropathol       Date:  2013-07-01

4.  Cocaine Use and Pulmonary Hypertension.

Authors:  Bashar N Alzghoul; Amjad Abualsuod; Bilal Alqam; Ayoub Innabi; Deepak R Palagiri; Zaid Gheith; Farah N Amer; Nikhil K Meena; Satish Kenchaiah
Journal:  Am J Cardiol       Date:  2019-11-19       Impact factor: 2.778

5.  Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung.

Authors:  Xuefeng Zhang; Susan Jiang; Jinlong Yu; Paula M Kuzontkoski; Jerome E Groopman
Journal:  Physiol Rep       Date:  2015-08

6.  A review on renal toxicity profile of common abusive drugs.

Authors:  Varun Parkash Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.